13F HOLDINGS REPORT
Essex Woodlands Management, Inc.
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0001398344-24-009624
Total Value
$344.8M
Positions
7
Other Managers
0
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MIMEDX GROUP, INC. | MDXG | 28,195,249 | $217.1M | 62.97% |
| 2 | BIOVENTUS | BVS | 13,021,324 | $67.7M | 19.64% |
| 3 | EYEPOINT PHARMACEUTICALS INC | EYPT | 1,551,521 | $32.1M | 9.30% |
| 4 | TELA BIO, INC. | TELA | 4,110,709 | $23.3M | 6.76% |
| 5 | REVANCE THERAPEUTICS INC | 761330109 | 457,085 | $2.2M | 0.65% |
| 6 | MEDICINOVA INC | MNOV | 1,105,941 | $1.6M | 0.47% |
| 7 | VENUS CONCEPT, INC. | VERO | 1,089,190 | $752,634 | 0.22% |